Valley Wealth Managers’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
DM
BG
Valley Wealth Managers's AMED Position: Q4 2022 in Review
Valley Wealth Managers sold out of Amedisys (AMED) in Q4 2022, closing a stake of 1,253 shares — an estimated $121K sold.
Valley Wealth Managers first reported a position in AMED in Q2 2021 and held it in 5 quarters. The position peaked at $240K in Q4 2021. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.
- Valley Wealth Managers reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
- Valley Wealth Managers sold 1,253 Amedisys shares in Q4 2022, an estimated $121K.
- Valley Wealth Managers first reported a position in Amedisys in Q2 2021 and held it in 5 quarters.
- Valley Wealth Managers's Amedisys position peaked at $240K in Q4 2021.
- 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.
Based on Valley Wealth Managers's 13F filing for Q4 2022, filed 1 Feb 2023.